Corbion's Calculated Handover: A Study in Corporate Stability

AMSTERDAM, NL – June 04, 2026 – In the often-turbulent world of corporate leadership, change at the top is typically a source of anxiety for investors and employees alike. Yet, the announcement from Corbion, the global leader in bio-based ingredients, feels different. The news that Ilona Haaijer, Chair of the Supervisory Board, will step down in August 2026 has been delivered not with a sense of crisis, but with a clear, two-year runway and a meticulously arranged succession plan. This transition is less a sudden departure and more a carefully orchestrated handover, offering a forensic look into how robust governance can serve as a company's bedrock.

Corbion announced that Haaijer, who has helmed the Supervisory Board for six years, will depart for personal reasons. In her place, current Vice Chair Liz Doherty will ascend to the Chair position until her term ends in May 2027. Bob Elfring, a recent addition to the board, will step into the Vice Chair role. This chain of command, promoted from within, signals a profound commitment to continuity over disruption.

In a statement, Haaijer reflected on her tenure and decision. "It has been a privilege to serve as Chair of Corbion," she said. "It is therefore with heartfelt regret that, due to changed circumstances, I have decided to rebalance my professional and private commitments and have decided to step down." Liz Doherty, the incoming Chair, expressed gratitude for Haaijer's "commendable leadership and commitment," noting her "meaningful contribution to the company, particularly in strengthening our governance and supporting the progression of our strategic priorities." CEO Olivier Rigaud echoed this sentiment, underscoring Haaijer's role in guiding the organization through a "challenging operating environment."

The Haaijer Era: Governance and Growth

To understand the significance of this transition, one must look at the foundation laid during Ilona Haaijer's tenure. Appointed in June 2020, she guided the Supervisory Board through the execution of the company's "Advance 2025" strategy. This ambitious plan was designed to sharpen Corbion's focus on its core competencies in sustainable food preservation and lactic acid, divesting non-core assets like its emulsifiers business and investing heavily in capacity and innovation.

Under her watch, the company navigated a complex global market while advancing its strategic goals. The financial results from this period speak to a steady hand at the helm. In 2025, Corbion reported sales of €1.27 billion and an adjusted EBITDA of €204.3 million, representing a 26.7% organic increase. This performance was not accidental; it was the result of a disciplined strategy to align Corbion’s portfolio with powerful market trends toward natural, sustainable solutions.

Haaijer’s legacy, as hinted by her colleagues, is deeply tied to the strengthening of the company’s governance frameworks. Her leadership ensured that as the company transformed its business portfolio, the underlying systems of oversight and strategic direction were reinforced, preparing the organization for its next chapter.

A New Guard with Deep Roots

The leadership duo stepping up is anything but new to the complexities of Corbion's business. Liz Doherty is the embodiment of continuity. Having served on the Supervisory Board since 2015 and as its Vice-Chair, she has been a key figure in the company’s strategic evolution for nearly a decade. Her background as a finance and accounting expert, with executive-level experience as CFO at giants like Reckitt Benckiser and Brambles, and senior roles at Unilever and Tesco, provides the board with profound financial acumen and international operational experience. Her current board positions at Novartis and Royal Philips NV further cement her status as a seasoned governance professional.

Complementing Doherty's deep institutional knowledge is Bob Elfring, the incoming Vice Chair. Though he only joined the board in May 2026, his appointment was a strategic move to infuse the board with top-tier financial expertise. With a thirty-year career in investment banking at institutions like J.P. Morgan, Bank of America Merrill Lynch, and Credit Suisse, Elfring brings an exceptionally strong background in corporate finance, capital markets, and M&A. This skill set is invaluable for a company executing a long-term growth strategy that involves significant capital allocation and potential strategic partnerships.

Together, Doherty and Elfring represent a powerful combination: one leader with deep, long-term company knowledge and another with world-class, external financial expertise. This is not a rookie team; it is a seasoned and complementary partnership designed to steer the ship without missing a beat.

Strategy Unchanged: The 'BRIGHT 2030' Roadmap

Any concern that a change in leadership might precipitate a change in direction appears unfounded. The transition is happening just as Corbion pivots from its "Advance 2025" plan to its next strategic chapter: "BRIGHT 2030." This new roadmap doubles down on the company's core mission, focusing on high-growth areas like label-friendly food preservation, algae-derived nutritional ingredients, and advanced biomaterials for healthcare applications.

The targets are ambitious: 3-6% annual organic sales growth, an adjusted EBITDA margin of around 18% by 2028, and significant free cash flow generation. The promotion of Doherty and Elfring, who were both involved in the development and approval of this strategy, is the clearest possible signal that the board intends to see it through. Their collective experience in finance, operations, and strategic capital allocation aligns perfectly with the demands of the BRIGHT 2030 plan.

This is not to say the path is without its challenges. Investors reacted cautiously when the BRIGHT 2030 strategy was first unveiled in late 2025, with shares dipping despite the ambitious outlook. The new leadership will be tasked with not only executing this strategy flawlessly but also with clearly communicating its value to a market that remains watchful. The stability of the board's leadership structure is a crucial element in building and maintaining that investor confidence.

A Masterclass in Succession Planning

Zooming out from Corbion, this transition serves as a case study in modern corporate governance. The departure of a long-serving chair could have created a vacuum, but the company's actions reflect a textbook approach to effective succession planning. By cultivating leadership from within the board, Corbion ensures that Doherty takes the helm with full context and no learning curve. The long notice period provided by Haaijer allows for a smooth, multi-year transition, preventing any disruption to the board's function.

Furthermore, the company is not standing still. The announcement confirms that a search for a new board member has already begun, demonstrating a proactive approach to identifying and filling potential gaps in expertise. This move, combined with the broader board refreshment seen in May 2026, shows that succession is viewed not as a one-time event, but as a continuous process of renewal and strategic alignment.

In an era defined by volatility, the quiet, deliberate, and transparent manner of Corbion's leadership transition is a powerful statement. It suggests that the true strength of an organization lies not just in its products or its market strategy, but in the structural integrity of its governance, which allows it to manage change with foresight and stability.